Loskutoff et al., 1983 - Google Patents
Interactions between fibrin and the plasminogen activators produced by cultured endothelial cellsLoskutoff et al., 1983
View HTML- Document ID
- 8026442814626819088
- Author
- Loskutoff D
- Mussoni L
- Publication year
External Links
Snippet
Serum-free conditioned medium (CM) from cultured bovine aortic endothelial cells (BAEs) was fractionated by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate and analyzed for plasminogen activator (PA) activity by fibrin autography. Distinct …
- 229950003499 FIBRIN 0 title abstract description 44
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases Endopeptidases (3.4.21-3.4.25) derived from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Loskutoff et al. | Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells | |
| Levin | Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. | |
| Mimuro et al. | Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor | |
| Hekman et al. | Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. | |
| Levin et al. | Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. | |
| Erickson et al. | Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. | |
| Heeb et al. | Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. | |
| Stump et al. | Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator. | |
| Levin et al. | Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. | |
| Van Zonneveld et al. | On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. | |
| Marlar et al. | Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme | |
| Rijken et al. | Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. | |
| Vassalli et al. | Amiloride selectively inhibits the urokinase‐type plasminogen activator | |
| Van Hinsbergh et al. | Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium | |
| Kunitada et al. | Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction | |
| Plow et al. | The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. | |
| Eaton et al. | Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. | |
| Harpel et al. | Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I. | |
| Mutch et al. | Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI | |
| Kohno et al. | Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity | |
| Erickson et al. | Denaturant-induced stimulation of the β-migrating plasminogen activator inhibitor in endothelial cells and serum | |
| Murano et al. | The inhibition of high and low molecular weight urokinase in plasma | |
| Anglés-Cano et al. | Effects of lipoprotein (a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator | |
| Barlow et al. | On the conversion of high molecular weight urokinase to the low molecular weight form by plasmin | |
| Loskutoff et al. | Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor |